Home/Filings/4/0001179022-15-000019
4//SEC Filing

GENTIVA HEALTH SERVICES INC 4

Accession 0001179022-15-000019

CIK 0001096142operating

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:23 PM ET

Size

21.7 KB

Accession

0001179022-15-000019

Insider Transaction Report

Form 4
Period: 2015-02-02
Weaver Charlotte A
Sr. VP, Chief Clinical Officer
Transactions
  • Disposition to Issuer

    Employee stock option (right to buy)

    2015-02-0230,0000 total
    Exercise: $26.43Exp: 2019-02-03Common stock (30,000 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2015-02-029,5000 total
    Exercise: $26.58Exp: 2018-01-05Common stock (9,500 underlying)
  • Disposition to Issuer

    Common stock

    2015-02-0299,7870 total
  • Disposition to Issuer

    Employee stock option (right to buy)

    2015-02-028,8000 total
    Exercise: $11.46Exp: 2020-02-19Common stock (8,800 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2015-02-0214,3000 total
    Exercise: $25.61Exp: 2017-01-06Common stock (14,300 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2015-02-0215,6000 total
    Exercise: $10.89Exp: 2021-02-19Common stock (15,600 underlying)
  • Disposition to Issuer

    Employee stock option (right to buy)

    2015-02-0230,0000 total
    Exercise: $19.89Exp: 2018-07-14Common stock (30,000 underlying)
Footnotes (7)
  • [F1]On February 2, 2015, Kindred Healthcare, Inc., a Delaware corporation ("Kindred"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger between the Issuer, Kindred and Kindred Healthcare Development 2, Inc., a Delaware corporation and a wholly-owned subsidiary of Kindred ("Merger Sub"), dated as of October 9, 2014 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of Kindred (the "Merger"). The number reported consists of the following: (i) 47,887 shares held directly by the reporting person, (ii) 19,700 shares of restricted stock that vested 100% as a result of the Merger, and (iii) 32,200 shares of restricted stock that did not vest as a result of the Merger. The Merger is more fully described in the Issuer's proxy statement/prospectus, dated December 18, 2014.
  • [F2]Pursuant to the Merger Agreement, on February 02, 2015, the effective date of the Merger, (i) each share held by the reporting person was exchanged for $14.50 in cash, without interest (the "Cash Consideration"), and 0.257 of a share of Kindred common stock (the "Stock Consideration" and together with the Cash Consideration, the "Merger Consideration"); (ii) each share of restricted stock that vested as a result of the Merger was exchanged for the Merger Consideration, subject to withholding taxes; and (iii) each share of restricted stock that did not vest as a result of the Merger received merger consideration in the form of a Kindred restricted cash award in the amount of the Cash Consideration and Kindred restricted shares in the amount of the Stock Consideration.
  • [F3]Pursuant to the Merger Agreement, on February 2, 2015, the effective date of the Merger, (i) each Issuer option that was outstanding immediately prior to the effective time with a per share exercise price below the sum of (a) the value of the Stock Consideration (based on the average closing price per share of Kindred common stock on the New York Stock Exchange for the ten consecutive trading days ending immediately prior to the closing date of the Merger (the "Kindred Closing Price")) and (b) the Cash Consideration, that is or will become vested as a result of the Merger, was canceled and converted into the right to receive an amount in cash equal to the Merger Consideration less the exercise price, subject to withholding taxes; and (ii) each Issuer option that was outstanding immediately prior to the effective time with a per share exercise price at or above the sum of (a) the value of the Stock Consideration (based on the Kindred Closing Price)
  • [F4](cont'd) and (b) the Cash Consideration or that will not vest as a result of the Merger was converted into an option to purchase a number of shares of Kindred common stock determined by multiplying the number of shares of Gentiva common stock subject to such Gentiva option by a fraction, the numerator of which is the sum of (A) the product of the Stock Consideration multiplied by the Kindred Closing Price and (B) the Cash Consideration and the denominator of which is the Kindred Closing Price.
  • [F5]The options vest in three equal annual installments beginning on the first anniversary of the date of grant, which was February 19, 2013.
  • [F6]The options vest in three equal annual installments beginning on the first anniversary of the date of grant, which was February 19, 2014.
  • [F7]The options are fully vested and exercisable.

Issuer

GENTIVA HEALTH SERVICES INC

CIK 0001096142

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001096142

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:23 PM ET
Size
21.7 KB